Sign in to continue:

Thursday, March 19th, 2026

Contel Technology Announces Winding Up Petitions Against Key Subsidiaries and Shareholding Changes – High Court Hearing Scheduled May 2026 12

Contel Technology Company Limited Faces Winding Up Petitions Against Key Subsidiaries

Contel Technology Company Limited (Stock Code: 1912) has made a supplemental announcement regarding winding up petitions filed against its principal subsidiaries, Flyring Electronics Limited and IH Technology Limited. This disclosure, made in accordance with the Hong Kong Listing Rules and the Securities and Futures Ordinance, contains several developments of significant importance to shareholders and potential investors.

Key Points from the Announcement

  • Winding Up Petitions Filed: Ms. Feng Tao, a former controlling shareholder, has filed winding up petitions against both Flyring Electronics Limited and IH Technology Limited, which are wholly-owned subsidiaries of Contel Technology. The petitions raise serious uncertainties regarding the ongoing operations and financial status of these key subsidiaries.
  • Clarification of Shareholding Structure:

    • At the time of Contel’s listing, the controlling shareholders included Mr. Lam Keung (current Chairman), Ms. Feng Tao (the petitioner), and Mr. Qing Haodong (spouse of Ms. Feng). Together, they acted in concert and controlled 75% of Contel’s issued share capital at listing.
    • Current controlling shareholder: P.Grand (BVI) Limited, wholly-owned by Mr. Lam Keung, now holds approximately 50.29% of the company’s issued shares (662,746,000 shares).
    • Ms. Feng Tao and Mr. Qing Haodong, through Kingtech (BVI) Ltd., currently hold 84,000,000 shares, representing only about 6.37% of the company’s capital, indicating a substantial reduction in their influence.
  • Financial Impact of Affected Subsidiaries:

    • Flyring Electronics Limited and IH Technology Limited are critical to Contel’s business, accounting for approximately 83% of the group’s total assets and 97% of its revenue as of 30 September 2025.
    • The outcome of the petitions could have a material impact on the company’s financial position, given the significance of these subsidiaries to the group.
  • Legal Proceedings and Timeline:

    • The High Court of Hong Kong has granted an extension for the subsidiaries to file and serve their affirmations opposing the petitions, with a new deadline set for 15 April 2026.
    • The hearing of the petitions is scheduled for 6 May 2026. The company stated that it is currently unable to predict the outcome of the hearing.

Critical Issues for Shareholders and Potential Market Impact

  • Potential Share Price Impact: The winding up petitions target subsidiaries responsible for the vast majority of Contel’s assets and revenue. Any adverse outcome could severely affect the company’s valuation, future profitability, and its ability to operate as a going concern.
  • Change of Control: The shift in controlling shareholding from the previous group (acting in concert) to P.Grand (BVI) Limited underlines a change in corporate governance and influence over the company.
  • Legal and Operational Uncertainty: The ongoing litigation introduces significant uncertainty to the group’s business operations and financial outlook, which may affect investor confidence and trigger volatility in the company’s share price.
  • Board Composition: The board is currently comprised of Mr. Lam Keung and Ms. Cheng Yu Pik as executive directors, with Mr. Chan Kwok Kuen Kenneth, Mr. Dan Kun Lei (Raymond), and Mr. Lai Man Shun serving as independent non-executive directors.

Investor Guidance

The company has advised shareholders and potential investors to exercise extreme caution in dealing with Contel Technology’s securities, given the high level of uncertainty and potential material adverse impact arising from the petitions.


Disclaimer: The above article is based on official filings by Contel Technology Company Limited as of 18 March 2026. The outcome of the legal proceedings is uncertain and could have significant implications for the company’s financial position and share price. Investors are urged to monitor further announcements and seek professional advice before making investment decisions.

View CONTEL Historical chart here



Zhaoke Ophthalmology Limited Announces Board Meeting to Approve 2025 Annual Results on March 25, 2026 1

Zhaoke Ophthalmology Limited Announces Upcoming Board Meetin...

   Ad